Javascript must be enabled to continue!
Abstract 868: A Cardiac Specific Branched Chain Aminotransferase Deletion Increases Insulin Stimulated Glucose Oxidation in the Mouse Heart
View through CrossRef
Impaired branched chain amino acid (BCAA) oxidation at the level of downstream BCAA catabolic enzymes cause cardiac insulin resistance and dysfunction. However, it is not known whether it is the accumulation of BCAAs or branched chain keto acids (BCKAs) due to impaired cardiac BCAA oxidation that result in these cardiac metabolic detrimental effects. Our objective was to inhibit cardiac branched chain aminotransferase (BCATm), the first enzyme in the BCAA oxidative pathway, which functions to produce BCKAs. We anticipate deletion of upstream BCAA catabolic enzyme will result in reduced cardiac BCAA oxidation and increase BCAAs but decrease BCKAs. Ten-week-old BCATm cardiac specific knockout (BCATm
-/-
) male mice and their α-MHC-Cre expressing wildtype littermates (WT-Cre
+/+
) received 6 intraperitoneal injections of tamoxifen (50 mg/kg). All mice were allowed a 6-week washout post-tamoxifen, following which 16-week-old mice were used to assess cardiac energy metabolism. Isolated working hearts were perfused with oxygenated Krebs–Henseleit solution, consisting of either 5mM [5-
3
H/U-
14
C] glucose, 0.8mM palmitate, 3%BSA, 0.5mM BCAA for glycolysis and glucose oxidation measurements, or 0.5mM glucose, 0.8mM [9,10-
3
H] palmitate, 3%BSA and 0.5mM [U-
14
C] BCAA from combination of 0.15mM leucine/isoleucine and 0.2mM valine for fatty acid oxidation and BCAA oxidation measurements respectively. There was no body weight, glucose tolerance or cardiac function differences observed in BCATm
-/-
mice compared to WT-Cre
+/+
mice (control). As expected, cardiac BCAA oxidation was significantly reduced in BCATm
-/-
mice compared to control, however, adding insulin after 30 min of perfusion did not change BCAA oxidation rates. Interestingly, glucose oxidation was significantly higher in BCATm
-/-
mice. Adding insulin further increased glucose oxidation in BCATm
-/-
mice. Additionally, the contribution of glucose oxidation to ATP production was significantly higher in the BCATm
-/-
mice compared to control. We conclude that impaired BCAA oxidation due to the upstream catabolic enzyme deletion increases cardiac insulin sensitivity. This also indicates that accumulation of BCKAs, not BCAAs, may be primarily contributing to cardiac insulin resistance.
Ovid Technologies (Wolters Kluwer Health)
Title: Abstract 868: A Cardiac Specific Branched Chain Aminotransferase Deletion Increases Insulin Stimulated Glucose Oxidation in the Mouse Heart
Description:
Impaired branched chain amino acid (BCAA) oxidation at the level of downstream BCAA catabolic enzymes cause cardiac insulin resistance and dysfunction.
However, it is not known whether it is the accumulation of BCAAs or branched chain keto acids (BCKAs) due to impaired cardiac BCAA oxidation that result in these cardiac metabolic detrimental effects.
Our objective was to inhibit cardiac branched chain aminotransferase (BCATm), the first enzyme in the BCAA oxidative pathway, which functions to produce BCKAs.
We anticipate deletion of upstream BCAA catabolic enzyme will result in reduced cardiac BCAA oxidation and increase BCAAs but decrease BCKAs.
Ten-week-old BCATm cardiac specific knockout (BCATm
-/-
) male mice and their α-MHC-Cre expressing wildtype littermates (WT-Cre
+/+
) received 6 intraperitoneal injections of tamoxifen (50 mg/kg).
All mice were allowed a 6-week washout post-tamoxifen, following which 16-week-old mice were used to assess cardiac energy metabolism.
Isolated working hearts were perfused with oxygenated Krebs–Henseleit solution, consisting of either 5mM [5-
3
H/U-
14
C] glucose, 0.
8mM palmitate, 3%BSA, 0.
5mM BCAA for glycolysis and glucose oxidation measurements, or 0.
5mM glucose, 0.
8mM [9,10-
3
H] palmitate, 3%BSA and 0.
5mM [U-
14
C] BCAA from combination of 0.
15mM leucine/isoleucine and 0.
2mM valine for fatty acid oxidation and BCAA oxidation measurements respectively.
There was no body weight, glucose tolerance or cardiac function differences observed in BCATm
-/-
mice compared to WT-Cre
+/+
mice (control).
As expected, cardiac BCAA oxidation was significantly reduced in BCATm
-/-
mice compared to control, however, adding insulin after 30 min of perfusion did not change BCAA oxidation rates.
Interestingly, glucose oxidation was significantly higher in BCATm
-/-
mice.
Adding insulin further increased glucose oxidation in BCATm
-/-
mice.
Additionally, the contribution of glucose oxidation to ATP production was significantly higher in the BCATm
-/-
mice compared to control.
We conclude that impaired BCAA oxidation due to the upstream catabolic enzyme deletion increases cardiac insulin sensitivity.
This also indicates that accumulation of BCKAs, not BCAAs, may be primarily contributing to cardiac insulin resistance.
Related Results
New and simple Ohmic definition of insulin resistance in lean and obese subjects
New and simple Ohmic definition of insulin resistance in lean and obese subjects
objective:: Insulin enhances the influx of glucose into cells. However, the relationship between glucose and insulin is complex and insulin sensitivity varies widely with age, ethn...
(Invited) A Protein-Based Artificial Receptor for Insulin Sensing
(Invited) A Protein-Based Artificial Receptor for Insulin Sensing
Insulin is one of the most important hormones that controls the glucose level in blood. Therefore, the investigation of insulin is very important for the diabetic research. There h...
Insulin Lispro: Its Role in the Treatment of Diabetes Mellitus
Insulin Lispro: Its Role in the Treatment of Diabetes Mellitus
OBJECTIVE:
To introduce a rapid-acting human insulin analog, insulin lispro; to review its pharmacology, therapeutics, pharmacokinetics, dosing guidelines, adve...
A Comparison of Basal and Insulin stimulated Glucose Transport in Rat Adipocyte Plasma Membranes
A Comparison of Basal and Insulin stimulated Glucose Transport in Rat Adipocyte Plasma Membranes
Specific D-glucose transport in plasma membranes prepared from control and insulin-treated rat adipocytes was measured using a recently developed dual isotope ([3H]-D-glucose and [...
Insulin Action During Pregnancy: Studies with the Euglycemic Clamp Technique
Insulin Action During Pregnancy: Studies with the Euglycemic Clamp Technique
To assess the mechanisms responsible for the insulin resistance associated with both normal human pregnancy and gestational-onset diabetes, we have measured exogenous glucose dispo...
In Vivo and In Vitro Glucose-Induced Biphasic Insulin Secretion in the Mouse
In Vivo and In Vitro Glucose-Induced Biphasic Insulin Secretion in the Mouse
The mechanisms underlying biphasic insulin secretion have not been completely elucidated. We compared the pattern of plasma insulin changes during hyperglycemic clamps in mice to t...
Effect of intranasal insulin on osteocalcin levels and postoperative delirium in elderly patients undergoing joint replacement
Effect of intranasal insulin on osteocalcin levels and postoperative delirium in elderly patients undergoing joint replacement
Abstract
Background
Recently, intranasal insulin has shown great promise in preventing perioperative neurocognitive disorders t...
Metabolic Effects of Hyperglycemia and Hyperinsulinemia on Fate of Intracellular Glucose in NIDDM
Metabolic Effects of Hyperglycemia and Hyperinsulinemia on Fate of Intracellular Glucose in NIDDM
Hyperglycemia in non-insulin-dependent diabetes mellitus (NIDDM) stimulates peripheral glucose uptake, which tends to compensate for impaired insulinmediated glucose uptake. The me...

